Biotin/streptavidin binding is the strongest noncovalent interaction known in nature (K d [dissociation constant], ϳ10 Ϫ15 M) (10) , and this tight binding is one of the most general tools for biological research and has been widely used for biomolecular detection (11, 12) , immobilization (14, 19) , and recovery (15) . Therefore, it is of great significance to biotinylate biomolecules, in particular, proteins without functional inhibition. For this purpose, the method for site-selective biotinylation of proteins had been developed using biotin ligase. Biotin ligase catalyzes the posttranslational biotinylation of biotin enzymes, such as acetyl coenzyme A (acetyl-CoA) carboxylase, and introduces biotin into a specific lysine residue of a biotin carboxyl carrier protein (BCCP), a subunit of biotin enzymes (13) . In early studies, BCCP (ϳ100 amino acid residues) had been fused with the proteins of interest for biotinylation by biotin ligase (7); however, there was a concern that fused BCCP might disrupt the function of target proteins. Recently, biotin acceptor peptides (BAPs) had replaced BCCP due to the advantage of small size. BAPs, with 15 to 23 amino acid residues, were screened from a peptide library as peptide tags biotinylated by Escherichia coli biotin ligase (4, 25) . BAP-fused proteins can be biotinylated outside the cells by adding biotin and purified E. coli biotin ligase with Mg 2ϩ and ATP (in vitro biotinylation). Furthermore, it is also possible to biotinylate BAP-fused proteins inside the cells with coexpression of E. coli biotin ligase (in vivo biotinylation) because BAP is specifically recognized only by E. coli biotin ligase. This in vivo biotinylation technology has been applied in eukaryotic cells to purify the proteins by using streptavidin-immobilized resin (8, 24, 28) , because biotin/streptavidin interaction permits stringent washing to eliminate the nonspecific binding. Specific biotinylation can be applied also for protein localization analysis. Using fluorophore-or gold nanoparticle-labeled streptavidin, biotinylated proteins were clearly observed in a previous study (27) . Recently, a novel technique to detect protein-protein interaction by fusing BAP and biotin ligase was developed by Ting's group. BAP and biotin ligase were fused to different two proteins, and then the interaction of these proteins was successfully evaluated via biotinylation of BAP (9) . In vivo biotinylation technology using heterologously expressed E. coli biotin ligase should be equally useful for prokaryotes; however, such studies have not been reported for bacterial cells.
Magnetospirillum magneticum AMB-1, a magnetotactic bacterium, synthesizes intracellular nanosized bacterial magnetic particles (BacMPs) of 50 to 100 nm; these are surrounded by a lipid bilayer membrane, possess a single magnetic domain of magnetite, and exhibit strong ferrimagnetism (18) . Furthermore, functional proteins have been displayed on BacMP surfaces through gene fusion techniques (21, 30, 31) . BacMP membrane proteins, including Mms13, were used as anchor proteins; this approach permits functional proteins to be localized efficiently and oriented appropriately on BacMPs (31) . We recently reported a novel method for the simple production of biotin-labeled magnetic particles through protein display techniques, where introduction of the biotin moiety onto BacMPs was carried out by the endogenous biotin ligase (17) . For the biotinylation of BacMPs, we screened the gene encoding BCCP in the AMB-1 genome and displayed it on the surface of BacMPs using an anchor protein, Mms13. BCCPdisplaying BacMPs were biotinylated by endogenous AMB-1 biotin ligase in the cells with high efficiency. This in vivo modification approach could be applied for construction of BacMP-quantum dot nanocomposites toward multicolor labeling of cancer cells, where BCCP and antibody carrier protein (protein G) were simultaneously displayed in tandem (16) . However, the size of BCCP, with 149 amino acid residues and a mass of 15.6 kDa, makes it rather large for use as a labeling tag. Although it would be preferable to use a smaller peptide, BAP, for the tag to minimize effects on the flanking proteins for future applications, BAP was not recognized and biotinylated by endogenous AMB-1 biotin ligase (17) .
In this study, in vivo biotinylation of BacMPs was attempted by heterologous expression of E. coli biotin ligase and Mms13-BAP fusion protein in AMB-1 cells. First, the method for effective expression of E. coli biotin ligase in bacterial cells was optimized. Then site-selective biotinylation of BAP on BacMPs was confirmed. Finally, the obvious advantage of in vivo biotinylation of BAP-displaying BacMPs compared with the in vitro biotinylation method was demonstrated.
MATERIALS AND METHODS
Materials. E. coli biotin ligase was purchased from Avidity L.L.C. (Aurora, CO). Chicken anti-biotin ligase antibody was purchased from ProSci Incorporated (Poway, CA). Alkaline phosphatase (ALP)-labeled anti-chicken/turkey IgG was from Invitrogen (Carlsbad, CA). ALP-labeled antibiotin antibody was purchased from Rockland Immunochemicals, Inc. (Gilbertsville, PA). ALP-labeled streptavidin was purchased from Millipore (Billerica, MA). Tetramethyl rhodamine isocyanate (TRITC)-labeled streptavidin was purchased from Beckman Coulter (Fullerton, CA). (ϩ)-Biotin, magnesium chloride hexahydrate, Lumi-Phos 530, and Tween 20 were purchased from Wako Pure Chemical Industries (Osaka, Japan). All other reagents were commercially available analytical reagents of laboratory grade. Deionized distilled water was used in all procedures.
Bacterial strains and culture conditions. E. coli strain EPI300 (AR Brown Co., Ltd., Tokyo, Japan) was used as a host for gene cloning. Cells were cultured in LB medium containing 50 g/ml ampicillin at 37°C. M. magneticum AMB-1 was microaerobically cultured in magnetic spirillum growth medium (MSGM) at 25°C as previously described (20) . Microaerobic conditions were established by purging the cultures with argon gas. AMB-1 transformants were cultured under the same conditions in the presence of 5 g/ml ampicillin.
Preparation of BacMPs. M. magneticum AMB-1 cells were collected by centrifugation at 11,344 ϫ g for 10 min at 4°C, resuspended in 40 ml 10 mM phosphate-buffered saline (PBS), pH 7.4, and disrupted by three passes through a French press cell (Ohtake Works Co. Ltd., Tokyo, Japan) at 1,500 kg/cm 2 . BacMPs were collected from the disrupted cell fraction using a columnar neodymium-boron (Nd-B) magnet and washed 10 times with 10 mM HEPES buffer, pH 7.4. The concentration of BacMPs in suspension was determined by measuring the optical density of the solution at 660 nm (OD 660 ) with a spectrophotometer (UV-2200; Shimadzu, Kyoto, Japan). A value of 1.0 corresponded to 172 g (dry weight) BacMPs/ml.
Construction of expression vectors. The plasmids pUMBL13B, pUM13B, pUMtBL13, and pUMtBL13B were derived from pUMP16 (Amp r ; 7.0 kbp; Fig.  1 ) (32) . For the construction of pUMBL13B and pUMtBL13B, the genes encoding intact biotin ligase and truncated biotin ligase were generated by PCR amplification using E. coli JM109 genomic DNA as a template and the primer sets XbaI-EcoRV-RBS-BL-R (5Ј-TTTTTCTAGAGATATCGTTATTCCTCCA ACCCGGTTATTTTTCTGCAC-3Ј) and XbaI-BL-F (5Ј-AAAATCTAGAATG AAGGATAACACCGTGCC-3Ј) or XbaI-tBL-F (5Ј-AAAATCTAGAATGAT CCAGTTACTTAATGCTAAAC-3Ј). Each PCR product was cloned into pCR4-BluntTOPO (Invitrogen, Carlsbad, CA). Plasmids were digested with XbaI, and the fragment containing the biotin ligase or truncated biotin ligase gene was cloned into SpeI-digested pUMP16. These plasmids were designated pUMBL and pUMtBL, respectively. The mms13-bap fusion gene was then amplified using pUMGP16M13 (31) as a template with the primer set Mms13-F (5Ј-ATGGTGAGCAAGGGCGC-3Ј) and BAP-Mms13-R (5Ј-TCACTCGTGC CATTCGATCTTCTGGGCCTCGAAGATGTCGTTCAGGCCGGCCAGTT CGTCCC-3Ј). The PCR product was cloned into EcoRV-digested pUMBL and pUMtBL. For the construction of pUMtBL13, the mms13 gene was amplified using pUMGP16M13 as a template and the primer set Mms13-F and EcoRVMms13-R (5Ј-TCAGATATCGGCCAGTTCGTCCC-3Ј). The PCR product was cloned into EcoRV-digested pUMtBL. For the construction of pUM13B, the mms13-bap fusion gene was amplified using pUMtBL13B as a template with the primer set XbaI-Mms13-F (5Ј-CCCCTCTAGAATGCCCTTTCACCTTGCC-3Ј) and XbaI-BAP-R (5Ј-GGGGTCTAGATCACTCGTGCCATTCGAT-3Ј). The PCR product was digested with XbaI and cloned into SpeI-digested pUMP16. Plasmids were transformed into wild-type M. magneticum AMB-1 by electroporation (23) .
SDS-PAGE and Western blotting. For detection of truncated E. coli biotin ligase expressed in M. magneticum AMB-1, 5 ϫ 10 8 AMB-1 cells were collected by centrifugation, suspended in 25 l 1% (wt/vol) SDS in aqueous solution, and boiled for 30 min. Following addition of SDS sample buffer to a final concentration of 62.5 mM Tris-HCl, pH 6.8, 5% 2-mercaptoethanol, 2% SDS, 5% sucrose, and 0.002% bromophenol blue, proteins were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) through a 12.5% (wt/vol) gel and transferred to a polyvinylidene difluoride membrane. Biotin ligase was detected using chicken anti-E. coli biotin ligase antibody (1/20,000 dilution from stock in PBS containing 0.05% Tween 20 [PBST] ) and ALP-labeled rabbit anti-chicken IgG (1/2,000 dilution from stock in PBST). BCIP/NBT-Blue (Sigma, St. Louis, MO) was used as the ALP substrate for visualization.
For detection of the biotin moiety on the Mms13-BAP fusion protein, aliquots of suspension containing 100 g BacMPs were dispensed to microtubes and the BacMPs were magnetically collected. on October 1, 2017 by guest http://aem.asm.org/ membrane proteins in the supernatant were mixed with SDS sample buffer, subjected to SDS-PAGE through a 20% (wt/vol) polyacrylamide gel, and transferred to a polyvinylidene difluoride membrane. Biotin was detected using ALPlabeled antibiotin antibody. In vitro biotinylation reaction. BacMPs (700 g) were magnetically collected using a columnar Nd-B magnet and suspended in 1,400 l PBS containing 15 g/ml E. coli biotin ligase, 10 M (ϩ)-biotin, 5 mM magnesium chloride hexahydrate, and 100 mM ATP disodium salt followed by incubation for 60 min at room temperature with pulsed sonication every 10 min. BacMPs were magnetically separated from the reaction mixture by using a Nd-B magnet and washed once with 1,400 l PBST with sonication.
Introduction of antibody or streptavidin to BacMPs. BacMPs (50 g) were magnetically collected and added to a solution of ALP-labeled antibiotin antibody (10 g/ml) or ALP-labeled streptavidin (1/100 dilution from stock in PBST) in 50 l PBST. Mixtures were incubated for 30 min at room temperature with pulsed sonication every 5 min. BacMPs were then magnetically separated, washed three times with 100 l PBST, and resuspended in 50 l PBS. Fifty microliters Lumi-Phos 530 was added as luminescence substrate. After 5 min of incubation, luminescence intensity was measured with a luminometer (Aloka, Tokyo, Japan).
BacMPs (100 g) were magnetically collected and added to 200 l TRITClabeled streptavidin in PBST. The mixture was incubated for 60 min at room temperature with pulsed sonication every 5 min. BacMPs were magnetically separated and washed three times with 200 l PBST followed by suspension of 50 g BacMPs in 500 l PBS and measurement of fluorescence intensity of the solution ( excitation ϭ 550 nm, emission ϭ 580 nm) using a spectrofluorometer (Horiba Itech, Tokyo, Japan). To estimate the amount of streptavidin bound to BacMPs, a calibration curve was constructed by measuring the fluorescent intensities of 500-l aliquots of PBS containing 50 g BacMPs and various concentrations of TRITC-labeled streptavidin.
RESULTS

Heterologous expression of E. coli biotin ligase and Mms13-BAP in M. magneticum AMB-1. For in vivo biotinylation of
BacMPs, E. coli biotin ligase was coexpressed in M. magneticum AMB-1 with BAP (GLNDIFEAQKIEWHE) fused to anchor protein Mms13, which is tightly bound to the BacMP surface. Two kinds of proteins were simultaneously expressed under the control of a strong promoter, P mms16 (30) , where both genes were aligned in tandem across the ribosome-binding site found in the same P mms16 (Fig. 1) . In the initial trial, an intact gene encoding the full length (321 amino acid residues) of the biotin ligase was cloned into expression vector pUMBL13B and introduced into wild-type AMB-1 by electroporation. After transformation, bacterial cells were cultured in MSGM containing ampicillin, and cell growth was monitored by microscopic observation. However, transformants harboring pUMBL13B were not obtained even after 3 weeks of culture, and it was speculated that full-length E. coli biotin ligase showed cytotoxicity when it was overexpressed in the bacterial cells. E. coli biotin ligase is a bifunctional protein and serves not only as a biotin-protein ligase but also as a biotin repressor, binding the biotin operator to repress transcription of the biotin biosynthetic operon (2, 3). E. coli biotin ligase has a DNA-binding domain (29) . Generally, overexpression of proteins containing a DNA-binding domain tends to show the cytotoxicity for host cells (5, 6) . Based on these observations, we hypothesized that the DNA-binding domain of E. coli biotin ligase is also cytotoxic in AMB-1 cells as a result of binding to chromosomal DNA and disturbing cellular metabolism. A truncated gene which encodes a truncated mutant of biotin ligase lacking the DNA-binding domain (⌬2K-63P, consisting of 259 amino acids) was cloned into the expression vector pUMtBL13B, and the growth of transformants harboring pUMBL13B and that of transformants harboring pUMtBL13B were compared. No growth of transformants expressing the intact form of biotin ligase was observed (Fig. 2, open circles) , while transformants expressing the truncated biotin ligase lacking the DNA-binding domain showed steady growth (Fig. 2,  closed circles) . Truncation of the DNA-binding domain permitted effective transformation of AMB-1.
Site-selective biotinylation of Mms13-BAP on BacMPs. To evaluate the biotinylation of BacMPs by heterologously expressed E. coli biotin ligase, a further two kinds of plasmids, in which truncated biotin ligase or bap was deleted from pUMtBL13B, were constructed (Fig. 1, pUM13B and pUMtBL13 ). Three kinds of plasmids (pUM13B, pUMtBL13, and pUMtBL13B) were respectively introduced into wild-type AMB-1, and heterologous expression of truncated biotin ligase in AMB-1 was analyzed by Western blotting using anti-biotin ligase antibody. Truncated E. coli biotin ligase was observed in the fraction of whole-cell lysates from pUMtBL13 and pUMtBL13B at the predicted mass (29 kDa) (Fig. 3) . In vivo attachment of biotin to BAP-displaying BacMPs (BAP-BacMPs) by truncated biotin ligase was evaluated (Fig. 4) . Figure 4A shows the principle of in vivo biotinylation in magnetotactic bacteria and purification of BAP-BacMPs. After extraction of BacMPs from wild-type AMB-1 and from transformants harboring pUM13B lacking the truncated biotin ligase gene, pUMtBL13 lacking the bap gene, and pUMtBL13B, BacMPs were exposed to ALP-labeled antibiotin antibody followed by addition of luminescence substrate and measurement of luminescence intensity. High luminescence intensity was observed in BAP-BacMPs extracted from pUMtBL13B transformants (Fig.  4B) . To confirm the specific biotinylation of the Mms13-BAP fusion proteins in pUMtBL13B transformants, the protein fraction of the BacMP membrane was analyzed by Western blotting with ALP-labeled antibiotin antibody and the specific band was observed at the predicted mass (Fig. 4C) .
Immobilization of streptavidin on BAP-BacMPs biotinylated in vitro or in vivo. The interaction between biotin and streptavidin is enormously stable. Therefore, various functional materials can be immobilized on biotinylated BacMPs. Here, we compared the amounts of streptavidin immobilized on BAP-BacMPs biotinylated in vitro and in vivo. In vitro ALP-labeled streptavidin was immobilized on BAP-BacMPs biotinylated in vivo and in vitro by simply mixing them. Then luminescence substrate was added and luminescence intensity was measured. In vitro biotinylation was confirmed by the observation of increased luminescence intensity compared to that of wild-type BacMPs (Fig. 5, inset) ; in vivo-biotinylated BAP- BacMPs showed 35-fold-greater luminescence than did in vitro-biotinylated particles (Fig. 5) , indicating that the biotinylation reaction of BAP-BacMPs in the bacterial cells (in vivo biotinylation) was much more effective than that outside the cells (in vitro biotinylation). The number of streptavidins immobilized on BacMPs was quantitated using TRITC-labeled streptavidin. Approximately 700 ng of streptavidin was immobilized per 1 mg of in vivo-biotinylated BAP-BacMPs, and this amount corresponds to eight molecules of streptavidin for a single in vivo-biotinylated BAP-BacMP (molecular mass of streptavidin, 60 kDa; BacMP diameter, 75 nm; BacMP density, 5.2 g/cm 3 ). Similar results were obtained in a previous study of in vivo biotinylation of BCCP-displaying BacMPs (17) .
DISCUSSION
Efficient biotinylation of BacMPs in magnetotactic bacteria was successfully demonstrated. For in vivo biotin labeling of BacMPs, E. coli biotin ligase and Mms13-BAP were overexpressed in AMB-1 cells. While in vivo biotinylation of BAPfused proteins by heterologously expressed E. coli biotin ligase is used as a powerful tool to characterize the protein of interest in eukaryotic cells, this is the first report to apply this method to prokaryotes. Initially, full-length biotin ligase was expressed and was observed to be cytotoxic to the AMB-1 cells. Similar toxicity has been reported in E. coli when biotin ligase was overexpressed (5, 6, 22) . Fusion of biotin ligase to glutathione S-transferase (GST) decreased the DNA-binding activity of biotin ligase in E. coli cells (22) . We employed the truncation approach to overcome the cytotoxic effect of biotin ligase. Site-directed mutagenesis of the bifunctional biotin ligase had revealed that the C-terminal domain of E. coli biotin ligase is required for catalytic activity (6) . Crystallographic analysis had also indicated that E. coli biotin ligase is composed of two domains; the N-terminal domain contains a helix-turn-helix motif for DNA binding and the C-terminal domain contains a biotin-or ATP-binding motif for biotin attachment. The Nand C-terminal domains are connected by a linker sequence (29) . Based on these findings, the N-terminal domain of E. coli biotin ligase was truncated to generate biotin ligase lacking the DNA-binding activity for use in this study. Although it is still a matter for speculation that the DNA-binding domain of E. coli biotin ligase can bind to AMB-1 genomic DNA and disturb the metabolism of host cells, this truncation strategy clearly permitted growth of the transformants harboring expression vectors for E. coli biotin ligase.
Simultaneous expression of the genes encoding truncated biotin ligase and Mms13-BAP was carried out under the control of the promoter P mms16 (30) . In vivo biotinylation of Mms13-BAP on BacMPs was confirmed using ALP-labeled antibiotin antibody. In previous work, we had already demonstrated the in vitro biotin labeling of BAP-displaying BacMPs by E. coli biotin ligase in the presence of biotin, Mg 2ϩ , and ATP after purification of BAP-BacMPs from AMB-1 transformants harboring plasmid pUM13BAP, which encodes the fusion protein of Mms13 and 23 amino acid residues of BAP (17) . However, the efficiency of in vitro biotinylation was quite low despite its being carried out under optimized conditions. In this study, we successfully demonstrated in vivo biotinylation of BAP-BacMPs with greater efficiency than in vitro biotinylation. This was likely due to the reaction environment for biotinylation of Mms13-BAP. In magnetotactic bacteria, synthesis of BacMPs is initiated with the invagination of the cytoplasmic membrane and with the vesicle formation which serves as the precursor of the BacMP membrane. Then, ferrous ions are accumulated in the vesicles and magnetite crystals are formed (1) . In this procedure, various proteins, including Mms13, are translocated from the cytoplasmic membrane to the BacMP membrane at the invagination stage (26) . For in vitro biotinylation, extracted BAP-BacMPs were mixed with purified E. coli biotin ligase, and interaction between Mms13-BAP and E. coli biotin ligase was limited on the surface of the BacMP membrane. In contrast, for in vivo biotinylation, Mms13-BAP could interact with E. coli biotin ligase not only on the surface of BacMPs but also in the cytoplasm or on the cytoplasmic membrane before the first stage of BacMP synthesis. Mms13-BAP is assumed to have a high mobility prior to translocation into the BacMP membrane in vivo, allowing for more efficient biotinylation relative to in vitro biotinylation. Actually specific biotinylation of Mms13-BAP in the cytoplasm and cytoplasmic membrane was detected by the Western blotting of each protein fraction (data not shown).
In conclusion, BacMPs were biotinylated in vivo by using the truncated form of E. coli biotin ligase and Mms13-BAP. Streptavidin was readily immobilized on biotinylated BacMPs. The conjugation system developed in this study provides a simple, low-cost method for producing biotin-and streptavidin-immobilized magnetic nanoparticles. This site-selective technique for modification of magnetic nanoparticles will be valuable in future development of functionalized magnetic conjugates. Furthermore, in vivo biotinylation of bacterial protein with coexpression of E. coli truncated biotin ligase can also be applied in basic studies, such as analysis of protein localization and protein-protein interaction in bacterial cells.
